Standard BioTools Inc. Debt Instrument, Basis Spread on Variable Rate
Standard BioTools Inc. (LAB) reported Debt Instrument, Basis Spread on Variable Rate of 0.50% for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-12.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 · last filed 2014-05-12
- Standard BioTools Inc. debt instrument, basis spread on variable rate for the quarter ending 2014-03-31 was 0.50%.
| Period end | Debt Instrument, Basis Spread on Variable Rate 1 month | Debt Instrument, Basis Spread on Variable Rate 3 month |
|---|---|---|
| 2014-03-31 | 0.50% 10-Q · filed 2014-05-12 | |
| 2010-12-31 | 1.00% 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |